BVT Call 165 PGR 21.06.2024/ DE000VM58AX6 /
| 6/5/2024 8:39:14 AM | Chg.- | Bid8:18:32 AM | Ask8:18:32 AM | Underlying | Strike price | Expiration date | Option type |
|---|---|---|---|---|---|---|---|
| 4.46EUR | - | 4.46 Bid Size: 3,000 |
4.54 Ask Size: 3,000 |
Progressive Corporat... | 165.00 USD | 6/21/2024 | Call |
GlobeNewswire
6/5
Intercept Presents New Data on the Results of OCA-Bezafibrate Combination Therapy in PBC After Six M...
GlobeNewswire
6/5
The Alignment Studio Physiotherapy Melbourne Celebrates Receiving Only 5-Star Reviews Since Opening
GlobeNewswire
6/5
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Preventio...
GlobeNewswire
6/5
Ipsen presents long-term elafibranor efficacy and itch-related quality of life data in patients with...
GlobeNewswire
6/4
Tiziana Life Sciences Submits Grant Application to ALS Association to Fund Clinical Trial of Intrana...
GlobeNewswire
6/4
Amicus Therapeutics Receives Prix Galien U.K. Award for Pombiliti® (cipaglucosidase alfa) + Opfolda®...
GlobeNewswire
6/3
MediciNova Announces Data from Phase 1b/2a Clinical Trial of MN-166 (ibudilast) in Glioblastoma Pati...
GlobeNewswire
5/31
TG Therapeutics Announces Presentations for BRIUMVI® (ublituximab) in Multiple Sclerosis at the 2024...
GlobeNewswire
5/30
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
5/30
4DMT to Present Interim Data from Aerosolized 4D-710 Phase 1/2 AEROW Clinical Trial for Cystic Fibro...
GlobeNewswire
5/30
BlueRock Therapeutics receives FDA Regenerative Medicine Advanced Therapy designation for Parkinson’...
GlobeNewswire
5/29
Spinogenix Announces FDA Clearance of IND Application for SPG302, a Novel Therapy for the Treatment ...
GlobeNewswire
5/28
Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin...
GlobeNewswire
5/28
Opthea Completes Enrollment in Pivotal Phase 3 Clinical Program with Sozinibercept in Wet AMD
GlobeNewswire
5/28
TG Therapeutics Announces Schedule of Upcoming Presentations for BRIUMVI® (ublituximab) in Multiple ...
GlobeNewswire
5/25
Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b OR...
GlobeNewswire
5/24
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Act...
GlobeNewswire
5/24
BriaCell Doubles Progression-Free-Survival (PFS) and Reports Clinical Benefit Data at ASCO 2024
GlobeNewswire
5/23
Candel Therapeutics Reports Prolonged Overall Survival in Phase 2 Clinical Trial of CAN-2409 for Adv...
GlobeNewswire
5/21
Sana Biotechnology Highlights Publication in Nature Biotechnology of Novel In Vivo Preclinical Data ...
